For months, Americans have been told a $2,000 tariff rebate check could be coming. It still hasn’t — and court rulings, shifting timelines and unanswered questions have only added to the confusion. In ...
In the second of a three-part webinar series on the recently enacted Inflation Reduction Act of 2022 (IRA), Hogan Lovells partners Alice Valder Curran and Ken Choe, as well as David Chan, President ...
Johnson & Johnson, Eli Lilly, Sanofi and Bristol Myers Squibb are suing the federal government over the future of their 340B drug rebate plans. The lawsuits reflect rising tensions among drugmakers, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results